ClinChoice is a full-service global clinical contract research organization (CRO) dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide.I was recruited to architect and direct next-stage go-to-market strategy positioning ClinChoice as a key global key player in the full-service clinical trial management services provider space. As such, I built and currently manage a new organization accelerating P&L performance and the sell-through of flexible solutions to pharmaceutical, biotechnology, and medical device firms via a multi-tiered organization in the US, Europe, and Asia comprised of Field Sales, Inside Sales, and RFx response management and contracting. Additionally, I collaborate with our Board of directors and had, until recently, led an internal Marketing organization. Key achievements:►Conceptualizing and implementing the next stage corporate vision as a core member of our Executive Leadership Team, amplifying the ROI on a recent Series E capital raise in partnership with Clinical Operations and key stakeholders.►Delivering double-digit YoY revenue growth (ahead of target) in three consecutive years, positioning ClinChoice as the onshore/offshore CRO of choice to over 150 active clients, including many top global pharma companies.►Driving execution through unified sales vision, marketing plans, and SOPs. I strengthened our internal talent profile, deployed new bidding tools and internal synergies, matured the research RFx and pricing models, and effectively leveraged our core clinical expertise.►Orchestrating the strategic and operational post-M&A purchase integrations of acquired subsidiaries, including liaising across our C-suite on the due diligence and in building the initial plan, as well as harmonizing the product portfolios, core workflows, and talent capabilities.►Building a high-performing organization with a deep bench of leadership.

I provided a broad portfolio of management consulting services within the CRO industry, performing gap analysis and providing guidance on short-term and long-term strategy, market positioning, service portfolio, opportunity scouting, and client penetration and retention plans.

CPI Global CRO was founded as a full-service CRO managing interventional clinical trials, non-interventional and observational studies across multiple therapeutic areas, with the intent to provide reliable, efficient, and accurate research services to the pharmaceutical and device industries.I was recruited to create and launch a new organization, building the ground-up strategy and managing the execution of the global strategy, business development, operations, and marketing functions. Key achievements:►Heading a high-performing organization cultivating full-cycle, enterprise-level relationships with pharmaceutical and biotechnology firms, coordinating RFx responses, negotiating high-value contracts, and driving P&L performance.►Ideating and managing transformative sales development, enablement, and performance programs, including training, systems, KPIs, and process improvements.►Rapidly stimulating top-tier sales performance and market awareness. We achieved double-digit and triple-digit RFP growth in successive years, strategically grew the customer base, doubled our alliance partnerships, and positioned the firm as an attractive PE target.

ICON is a CRO offering a full range of consulting, development, and commercialization services from a global network of offices in 53 countries.I conceptualized and executed the business strategy and P&L performance as the owner of ICON’s core Peri-Approval and Observational Research business. With full accountability for top-line and bottom-line results, I directed a multi-tiered matrixed organization spanning clinical, operations, sales, marketing, administration, safety surveillance, and other components of the commercial operations including culture, go-to-market strategy, market positioning, service delivery, and KPI performance. Key achievements:►Executing strategies supporting Icon’s positioning as the world’s largest provider of commercial services. We delivered a rapid positive margin swing through an improved value proposition capitalizing on market dynamics.►Playing an integral role in the planning, due diligence, portfolio integration, and sales and operations upgrades of four acquired companies in five years.►Deepening service impact and reducing client turnover via the maximization of the service portfolio.►Serving as the executive sponsor for multiple commercial clients, and directing the medical device and NIS service level development.►Partnering across the senior leadership team on Lean Six Sigma programs as a member of the Standard Operating Procedure (SOP) Committee, driving cross-functional teams analyzing processes, streamlining service, and producing cost savings.►Increasing revenue performance through the program management of a series of enterprise sales enablement programs.►Developing and promoting talent into elevated roles across the company via hands-on coaching and dynamic task maturity assignments.

PPD, now a Thermo Fisher Scientific Company, offers a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.I initially joined PPD managing proposals and contracts, and was rapidly promoted through successive roles in clinical operations to ultimately direct key account management and strategic development for a group within the division with a $400M+ P&L. Key achievements:►Heading an organization of 125 managers and staff in our clinical centers executing 65 active trials in the US, Brazil, and Mexico City serving the full Americas region.►Generating sustained business growth by leading gap analysis, optimizing the sales structure, improving our client partnerships and retention rates, and sharpening the end-to-end go-to-market planning and execution.